Skip to content

Provides lidocaine spray sufficient analgesia for intravenous cannulation.

A Randomized Clinical Trial of Cutaneous Xylocaine Spray to Reduce Intravenous Cannulation Pain in Adults. - Cutaneous xylocaine spray versus placebo spray

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2015-003915-39-NL
Enrollment
Unknown
Registered
2016-02-29
Start date
2016-03-07
Completion date
Unknown
Last updated
2016-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The enrolled subjects will get an intravenous cannulation in both elbows. The subject will get before xylocaine spray is placed, the intervention-arm, one intravenous cannulation in one of the elbows, the other intravenous cannulation is placed in de other arm before placebo spray is placed, the control arm. The pain score during insertion of de cannulation, the incidence of adverse events and the success rate and degree of difficulty to place an intravenous cannulation.

Interventions

Product Name: Xylocaine spray Product Code: D04AB01 Pharmaceutical Form: Cutaneous spray INN or Proposed INN: Xylocaine CAS Number: 137-58-6 Other descriptive name: LIDOCAINE Concentration unit: mg mi

Sponsors

None listed

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adults (aged 18 or older) Signing of the informed consent paper Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 17 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Allergy for xylocaine Pregnancy or breast-feeding Peripheral neuropathy Analgesics in the last 24 hours Skin conditions (eczema, psoriasis, infection, or abrasions) Difficulties in verbal communication No intravenous access in both elbows possible (eg status after axillary dissection)

Design outcomes

Primary

MeasureTime frame
Main Objective: Has xylocaine spray an analgesic effect during the insertion of an intravenous cannulation?;Secondary Objective: Are there any side effects when using xylocaine spray? Does xylocaine spray affect the successful placement of an intravenous cannulation?;Primary end point(s): The pain score of the tested subjects during intravenous cannulation.;Timepoint(s) of evaluation of this end point: When all subjects were enrolled and data processing has been completed.

Secondary

MeasureTime frame
Secondary end point(s): Complications or adverse reactions of xylocaine spray Influence of xylocaine spray in successfully placing an IV cannulation The degree of difficulty in successfully placing an IV cannulation;Timepoint(s) of evaluation of this end point: When all subjects were enrolled and data processing has been completed.

Countries

Netherlands

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026